At ATTD 2026, Dexcom (Nasdaq:DXCM) outlined a range of ways in which its continuous glucose monitors (CGMs) benefit people with diabetes. Notably, new registry data demonstrated that long-term use of the Dexcom G7 CGM supports weight management and lowers A1C for people with type 2 diabetes who aren’t on insulin therapy. Analysts recently said that […]
ATTD 2026
SiBionics highlights benefits of AI in CGM tech
SiBionics shared new findings about the use of AI in continuous glucose monitor (CGM) technologies. The China-based company shared new perspectives on AI at the 19th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in Barcelona. It outlined how AI can extend the value of CGM technology beyond just monitoring. SiBionics develops the […]
Senseonics reports sustained year-long CGM implant outcomes, insulin pump integration benefits
Senseonics (Nasdaq:SENS) announced new data from a real-world study demonstrating the sustained performance of its Eversense 365 CGM. Real-world evidence demonstrated the long-term performance and positive impact of the world’s first year-long continuous glucose monitor (CGM). The company shared findings at the 19th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in Barcelona. […]
Afon Technology highlights accuracy of non-invasive blood glucose monitor
Afon Technology says that its Glucowear non-invasive blood glucose monitor demonstrated significant accuracy in its first trial. The Monmouthshire, UK-based company says its device achieved approximately 75% overall accuracy in distinguishing between normal and elevated blood glucose levels in the initial evaluation of the technology. CEO Sabih Chaudhry wore the device, testing it during his […]
Abbott study highlights better glucose outcomes with Libre CGM in type 2 diabetes on basal insulin
Abbott (NYSE:ABT) today announced results from a trial demonstrating better glucose outcomes for users of continuous glucose monitors (CGMs). The FreeDM2 randomized controlled trial evaluated whether real-time CGM can help people with type 2 diabetes using basal insulin improve their glucose management. It took place across 24 clinical sites in the UK, evaluating 303 participants. […]
Abbott data highlights burden of diabetic ketoacidosis
Abbott (NYSE:ABT) today announced new real-world data highlighting the growing global burden of diabetic ketoacidosis (DKA). DKA occurs when ketones build up in the blood to dangerous levels. According to Abbott, DKA is a leading cause of death for people under 58 with type 1 diabetes. While traditionally associated with type 1, it’s also increasingly […]
Insulet shares study outcomes supporting fully closed-loop insulin pump for type 2 diabetes
Insulet (Nasdaq:PODD) today shared new clinical evidence for its first fully closed-loop automated insulin delivery system for type 2 diabetes. The maker of the Omnipod 5 — the world’s first available tubeless, wearable, automated insulin delivery system — said during a 2025 Investor Day event that it plans to bring its first fully closed-loop system […]
Dexcom highlights breakthrough type 2 diabetes outcomes at ATTD
Dexcom (Nasdaq:DXCM) today announced its plans to share new data supporting its diabetes management technology at ATTD 2026. San Diego-based Dexcom plans to highlight the benefits of its continuous glucose monitor (CGM) biosensor technology for people with all types of diabetes across the 19th annual Advanced Technologies and Treatments for Diabetes Conference in Barcelona this […]
MiniMed picks up CE mark for MiniMed 780G pump with Instinct sensor made by Abbott
MiniMed (Nasdaq:MMED) announced today that it received CE mark for the use of its MiniMed 780G with the Instinct sensor made by Abbott. Northridge, California-based MiniMed — which just went public as part of its separation from Medtronic — now offers more sensor choices for users of its most advanced automated insulin delivery system. The […]
CamDiab introduces fully closed-loop automated insulin delivery tech
CamDiab announced today that it is introducing CamAPS Liberty, a fully closed-loop feature for its CamAPS FX app. The integration of Liberty — which the company labeled the world’s first fully closed-loop feature — supports users with type 1 diabetes when daily demands prove challenging. It pauses the need to count carbohydrates or deliver meal […]
